Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN)

Clinical trial NCT01069835 · COMPLETED

Trial details

NCT number: NCT01069835
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer

Start date: 2010-02-01
Primary completion: 2011-03-01
Enrollment: 840

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.